- Pathologically confirmed diagnosis of stage IIIB/IV recurrent squamous cell NSCLC who has received systemic therapy. OR Pathologically confirmed diagnosis of stage III/IV recurrent or metastatic HNSCC (oral cavity, pharynx, larynx) who had received systemic therapy.